Welcome to our dedicated page for Newsmax news (Ticker: NMAX), a resource for investors and traders seeking the latest updates and insights on Newsmax stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Newsmax's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Newsmax's position in the market.
Newsmax has successfully completed its initial public offering (IPO) under Regulation A+, raising $75 million through the sale of 7.5 million shares of Class B Common Stock at $10.00 per share. The company's stock will begin trading on the New York Stock Exchange under the symbol 'NMAX' on March 31, 2025.
Prior to the IPO, Newsmax completed a private Preferred Offering in February 2025, raising $225 million. The company, founded in 1998 as a digital media brand, entered the cable news market in 2014 and has grown to become the fourth highest-rated cable news channel in the U.S., positioned behind CNN. The Reuters Institute has recognized Newsmax as one of the top 12 news brands in the U.S.
